Dec 06, 2023 |
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
|
PDF
|
Nov 09, 2023 |
Oncocyte Reports Third Quarter 2023 Financial Results
|
PDF
|
Nov 03, 2023 |
Oncocyte to Announce Third Quarter 2023 Financial Results
|
PDF
|
Sep 18, 2023 |
Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
|
PDF
|
Aug 28, 2023 |
Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
|
PDF
|
Aug 10, 2023 |
Oncocyte Reports Second Quarter 2023 Financial Results
|
PDF
|
Aug 09, 2023 |
Oncocyte Regains Compliance With Nasdaq Listing Requirements
|
PDF
|
Aug 08, 2023 |
Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
|
PDF
|
Aug 03, 2023 |
Oncocyte To Announce Second Quarter 2023 Financial Results
|
PDF
|
Jul 25, 2023 |
VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients
|
PDF
|